Glaucoma screening in Kazakhstan

Abstract This study aimed to conduct a comprehensive analysis of the national glaucoma screening program in Kazakhstan from 2000 to 2022. A thorough search was conducted to identify policy documents regulating the provision of glaucoma screening from its inception to the present day. Official data o...

Full description

Saved in:
Bibliographic Details
Main Authors: Malika Urazhanova, Elvira Kadraliyeva, Zhibek Dautbayeva, Yuliya Semenova
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-12540-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849344769689387008
author Malika Urazhanova
Elvira Kadraliyeva
Zhibek Dautbayeva
Yuliya Semenova
author_facet Malika Urazhanova
Elvira Kadraliyeva
Zhibek Dautbayeva
Yuliya Semenova
author_sort Malika Urazhanova
collection DOAJ
description Abstract This study aimed to conduct a comprehensive analysis of the national glaucoma screening program in Kazakhstan from 2000 to 2022. A thorough search was conducted to identify policy documents regulating the provision of glaucoma screening from its inception to the present day. Official data on reimbursement for tonometry, glaucoma incidence, and the population aged ≥ 50 years were retrieved. Forecast modeling was utilized to project disease incidences up to 2030. The current program largely inherits the framework of the Soviet glaucoma screening, with tonometry serving as the primary screening tool. The budget allocated for glaucoma screening is not specified in official documents, as glaucoma screening is integrated into the routine activities of healthcare facilities. The highest costs are incurred when Maklakov tonometry is applied alone, reaching 7,557,679,411 Kazakhstani Tenge in 2023. The incidence of glaucoma increased from 59.1 per 100,000 in 2000 to 135.5 in 2022, reflecting the aging population. Disparities in incidence rates were observed between residents of urban and rural areas, as well as among residents of different provinces. It is anticipated that the incidence of glaucoma will continue to rise, reaching 154.5 per 100,000 in 2030. There is a need to initiate a discussion on potential amendments to the existing screening program.
format Article
id doaj-art-e236c0adc16d4f5691204c27cf6163b0
institution Kabale University
issn 2045-2322
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e236c0adc16d4f5691204c27cf6163b02025-08-20T03:42:35ZengNature PortfolioScientific Reports2045-23222025-08-0115111110.1038/s41598-025-12540-3Glaucoma screening in KazakhstanMalika Urazhanova0Elvira Kadraliyeva1Zhibek Dautbayeva2Yuliya Semenova3Semey Medical UniversityNpJSC “Astana Medical University”NpJSC “Astana Medical University”Nazarbayev University School of MedicineAbstract This study aimed to conduct a comprehensive analysis of the national glaucoma screening program in Kazakhstan from 2000 to 2022. A thorough search was conducted to identify policy documents regulating the provision of glaucoma screening from its inception to the present day. Official data on reimbursement for tonometry, glaucoma incidence, and the population aged ≥ 50 years were retrieved. Forecast modeling was utilized to project disease incidences up to 2030. The current program largely inherits the framework of the Soviet glaucoma screening, with tonometry serving as the primary screening tool. The budget allocated for glaucoma screening is not specified in official documents, as glaucoma screening is integrated into the routine activities of healthcare facilities. The highest costs are incurred when Maklakov tonometry is applied alone, reaching 7,557,679,411 Kazakhstani Tenge in 2023. The incidence of glaucoma increased from 59.1 per 100,000 in 2000 to 135.5 in 2022, reflecting the aging population. Disparities in incidence rates were observed between residents of urban and rural areas, as well as among residents of different provinces. It is anticipated that the incidence of glaucoma will continue to rise, reaching 154.5 per 100,000 in 2030. There is a need to initiate a discussion on potential amendments to the existing screening program.https://doi.org/10.1038/s41598-025-12540-3Glaucoma screeningIncidenceBudget impact analysisTime seriesKazakhstan
spellingShingle Malika Urazhanova
Elvira Kadraliyeva
Zhibek Dautbayeva
Yuliya Semenova
Glaucoma screening in Kazakhstan
Scientific Reports
Glaucoma screening
Incidence
Budget impact analysis
Time series
Kazakhstan
title Glaucoma screening in Kazakhstan
title_full Glaucoma screening in Kazakhstan
title_fullStr Glaucoma screening in Kazakhstan
title_full_unstemmed Glaucoma screening in Kazakhstan
title_short Glaucoma screening in Kazakhstan
title_sort glaucoma screening in kazakhstan
topic Glaucoma screening
Incidence
Budget impact analysis
Time series
Kazakhstan
url https://doi.org/10.1038/s41598-025-12540-3
work_keys_str_mv AT malikaurazhanova glaucomascreeninginkazakhstan
AT elvirakadraliyeva glaucomascreeninginkazakhstan
AT zhibekdautbayeva glaucomascreeninginkazakhstan
AT yuliyasemenova glaucomascreeninginkazakhstan